Skip to main content
. Author manuscript; available in PMC: 2008 Jun 3.
Published in final edited form as: Diabetes. 2005 Jun;54(6):1698–1705. doi: 10.2337/diabetes.54.6.1698

FIG. 8.

FIG. 8

PIP3 corrects defects in Akt-1 but not GLUT4 or actin. PIP3 add-back was performed as described for PIP2 add-back in Fig. 6. Shown are cell PIP3 (A), membrane GLUT4 (C), cell F-actin (D), and a phosphoserine Akt immunoblot (B). All data shown are representative from 3–5 experiments. IF, immunofluorescence; PM, plasma membrane.